Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging by González-Navarro, Herminia et al.
Increased dosage of Ink4/Arf protects against glucose
intolerance and insulin resistance associated with aging
Herminia Gonzalez-Navarro,1* Angela Vinue,2* Marıa Jesus
Sanz,1,3 Mercedes Delgado,4 Miguel Angel Pozo,4 Manuel
Serrano,5 Deborah J. Burks6 and Vicente Andres7
1Institute of Health Research-INCLIVA, Valencia, 46010, Spain
2Vascular Biology Unit, Department of Molecular and Cellular Pathology and
Therapy, Instituto de Biomedicina de Valencia (IBV), Spanish Council for
Scientific Research (CSIC), Valencia, 46010, Spain
3Departamento de Farmacologıa, Universidad de Valencia-INCLIVA, Valencia,
46010, Spain
4CAI Cartografıa Cerebral, Instituto Pluridisciplinar, Universidad Complutense
de Madrid, Madrid, 28040, Spain
5Spanish National Cancer Research Center (CNIO), Madrid, 28029, Spain
6CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM), Centro de
Investigacion Prıncipe Felipe (CIPF), Valencia, 46012, Spain
7Laboratory of Molecular and Genetic Cardiovascular Pathophysiology,
Department of Epidemiology, Atherothrombosis and Imaging, Centro
Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain
Summary
Recent genome-wide association studies have linked type-2
diabetes mellitus to a genomic region in chromosome 9p21 near
the Ink4/Arf locus, which encodes tumor suppressors that are
up-regulated in a variety of mammalian organs during aging.
However, it is unclear whether the susceptibility to type-2
diabetes is associated with altered expression of the Ink4/Arf
locus. In the present study, we investigated the role of Ink4/Arf in
age-dependent alterations of insulin and glucose homeostasis
using Super-Ink4/Arf mice which bear an extra copy of the entire
Ink4/Arf locus. We find that, in contrast to age-matched wild-type
controls, Super-Ink4/Arf mice do not develop glucose intolerance
with aging. Insulin tolerance tests demonstrated increased insu-
lin sensitivity in Super-Ink4/Arf compared with wild-type mice,
which was accompanied by higher activation of the insulin
receptor substrate (IRS)-PI3K-AKT pathway in liver, skeletal
muscle and heart. Glucose uptake studies in Super-Ink4/Arf mice
showed a tendency toward increased 18F-fluorodeoxyglucose
uptake in skeletal muscle compared with wild-type mice
(P = 0.079). Furthermore, a positive correlation between glucose
uptake and baseline glucose levels was observed in Super-Ink4/
Arf mice (P < 0.008) but not in wild-type mice. Our studies reveal
a protective role of the Ink4/Arf locus against the development of
age-dependent insulin resistance and glucose intolerance.
Key words: 18F-fluorodeoxyglucose-PET; ARF; CDKN2A;
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Introduction
Patients with type 2 diabetes mellitus (T2DM) are at higher risk for
developing cardiovascular disease and have a shorter lifespan compared
with the general population (Benetos et al., 2008). T2DM is increasing
worldwide at alarming rates due to unhealthy lifestyles (e.g., lack of
exercise, excessive caloric intake) and to population aging (Beckman
et al., 2002; Nunn et al., 2009). It is well established that aged cells are
more susceptible to the development of chronic diseases; however, the
underlying molecular mechanisms are not completely understood
(Sharpless & DePinho, 2007).
Both environmental and genetic factors play a major role in the
etiopathogenesis of T2DM. Recent human genome-wide association
studies and candidate gene approaches using large cohorts have linked
common single nucleotide polymorphisms (SNPs) in a region of
chromosome 9p21 in close vicinity to the Ink4a/Arf/Ink4b locus (hereby
abbreviated as Ink4/Arf) with aging-associated frailty and a variety of
aging-related diseases, including coronary artery disease, myocardial
infarction, stroke, and T2DM (Consortium, 2007; Melzer et al., 2007;
Saxena et al., 2007; Scott et al., 2007; Sharpless & DePinho, 2007;
Zeggini et al., 2007; Doria et al., 2008; Hamsten & Eriksson, 2008). The
Ink4/Arf locus is one of the main anti-oncogenic defenses of mammalian
cells and its loss is among the most frequent cytogenetic events in
human cancer (Gil & Peters, 2006). Ink4/Arf encodes the tumor
suppressors p16Ink4a and ARF (p14ARF in humans, p19Arf in mice)
(CDKN2A gene) and p15INK4b (CDKN2B gene). In humans, the locus also
contains the CDKN2BAS gene, which produces a noncoding antisense
RNA named ANRIL (antisense noncoding RNA in the INK4 locus) that is
thought to regulate CDKN2A and CDKN2B expression (reviewed in)
(Cunnington & Keavney, 2011). p16Ink4a and p15Ink4b block cell
proliferation through the inhibition of CDK4,6/cyclin D kinases and the
ensuing accumulation of the hypophosphorylated form of the retino-
blastoma protein (Vidal & Koff, 2000).
ARF appears to play a relevant role as a pro-apoptotic factor via
inhibition of MDM2, an ubiquitin ligase that destabilizes the tumor
suppressor p53 (Gonzalez & Serrano, 2006). Several studies in mice and
humans have demonstrated an age-dependent increase of Ink4/Arf
expression in different tissues, which might limit the regenerative
potential of stem cell pools (Zindy et al., 1997; Krishnamurthy et al.,
2004; Ressler et al., 2006; Collado et al., 2007). These observations
have been generally interpreted as indicative of a pro-aging role for the
Ink4/Arf locus. However, various lines of evidence indicate that maximal
regenerative potential may be detrimental for the long-term mainte-
nance of stem cell pools. For example, deletion of the tumor suppressors
Lkb1, Pten, Apc, p21Cip1, weakens stem cell quiescence and results in
premature exhaustion of stem cell function (Kippin et al., 2005; Zhang
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et al., 2006; Qian et al., 2008; Gan et al., 2010; Gurumurthy et al.,
2010). In this context, aging-induced Ink4/Arf expression could represent
an anti-aging defensive response to prevent the exhaustion of stem cell
pools. Indeed, Ink4/Arf gain-of-function in transgenic mice confers
beneficial cancer-resistant phenotypes and elicits a global anti-aging
effect (Matheu et al., 2004, 2009). Moreover, p16Ink4a and p19Arf
expression protects from atherosclerosis development in the mouse
(Gonzalez-Navarro et al., 2010; Kuo et al., 2011). In further support
of a beneficial effect of the Ink4/Arf locus on aging-associated
diseases, in the case of the human SNP linked to atherosclerosis, the
susceptibility allele is associated with lower levels of Ink4/Arf expres-
sion than the normal allele (Liu et al., 2009). Thus, it remains to be
established whether the Ink4/Arf locus is a general pro-aging gene, a
general anti-aging gene, or, alternatively, whether its effects are tissue
specific.
In the present study, we investigated the impact of increased dosage
of Ink4/Arf on insulin and glucose homeostasis during normal physio-
logical aging. To this end, we utilized transgenic Super-Ink4/Arf mice
bearing an extra allele of the entire Ink4/Arf locus that behaves similarly
to the endogenous gene, with minimal expression in primary embryonic
cells and up-regulation in response to mitogenic overstimulation
(Matheu et al., 2004). Compared with wild-type (WT) controls, aged
Super-Ink4/Arf mice display moderately increased levels of p16Ink4,
p15Ink4b, and p19Arf in a number of tissues, yet they exhibit higher
resistance to both chemically induced cancer and aging-associated
spontaneous cancer (Matheu et al., 2004, 2007). In the present work,
we characterized carbohydrate metabolism and b-cell function in 0.5-
and 1-year-old Super-Ink4/Arf mice and age-matched WT littermates. As
defective signaling through insulin receptor substrate (IRS)-PI3K-AKT has
been associated with T2DM and insulin resistance (Withers et al., 1998;
Cho et al., 2001; Gonzalez-Navarro et al., 2008), we also examined this
pathway in both groups of mice.
Results
Ink4/Arf locus expression studies in Super-Ink4/Arf and
WT mice
To analyze the role of the locus Ink4/Arf in age-associated glucose
homeostasis, we first characterized gene expression in tissues relevant
for carbohydrate metabolism in both transgenic Super-Ink4/Arf and WT
mice. Fig. 1A depicts the structure of the transgene used to generate
Super-Ink4/Arf, consisting of the entire Ink4/Arf locus under the control
of its own promoter that behaves similarly to the endogenous gene
(Matheu et al., 2004). Quantification by qPCR showed a modest
increase in p16Ink4a, p15Ink4b, and p19Arf mRNA expression in liver of
Super-Ink4/Arf mice compared with WT mice, although differences
were only statistically significant for p15Ink4b (Fig. 1B). In skeletal
muscle, heart, and isolated islets, no significant differences in transcript
levels were observed, and p19Arf was not detected in skeletal muscle
(Fig. 1B). Protein expression analysis also revealed a modest but not
significant increase in hepatic p16Ink4a, p15Ink4b, and p19Arf protein
levels in Super-Ink4/Arf compared with WT mice (Fig. 1C). In agree-
ment with our qPCR studies, Western blot analysis revealed no
differences in skeletal muscle, heart, and isolated islets from mice of
both genotypes (Fig. 1C). Despite modest changes in the expression of
the gene products of the locus, Super-InK4/Arf macrophages showed a
significant increase in apoptosis compared with WT controls (Fig. 1D),
demonstrating an enhanced functionality of the extra dosage of the
locus in transgenic animals.
Super-Ink4/Arf mice are protected against the age-associated
decline of glucose homeostasis
To investigate the role of Ink4/Arf in carbohydrate metabolism associ-
ated with aging, WT and Super-Ink4/Arf mice were analyzed at 0.5 and
1 year of age. Body weight increased significantly with age in both WT
and Super-Ink4/Arf mice, and no differences were observed between
genotypes (P > 0.05) at any of the time points in our study (Fig. 2A).
However, while fasting plasma glucose levels were undistinguishable
between 0.5-year-old WT and Super-Ink4/Arf mice, glucose levels were
significantly increased in 1-year-old WT mice but not in age-matched
Super-Ink4/Arf mice (Fig. 2B). Aging also affected differentially fasting
plasma insulin levels in mice of both genotypes. Thus, no differences
were observed between 0.5-year-old WT and Super-Ink4/Arf mice, but
insulin levels were lower in Super-Ink4/Arf mice at 1 year of age
(Fig. 2C). Although altered glucose homeostasis and hypercholesterol-
emia (Nunn et al., 2009) are often associated with aging, neither aging
nor increased gene dosage of Ink4/Arf affected circulating levels of total
cholesterol and HDL-cholesterol (Fig. 2D, E).
We next performed glucose tolerance tests (GTT) in fasted mice.
Glucose tolerance, as revealed by the area under the curve (glucose
curve vs time, AUCglucose), was similar in 0.5-year-old WT and Super-
Ink4/Arf mice (Fig. 3A). At 1 year of age, the AUCglucose increased
significantly in WT as compared with 0.5-year-old mice but not in
Super-Ink4/Arf mice (Fig. 3A). Likewise, analysis of the corresponding
glucose-stimulated insulin release, expressed as AUCinsulin, revealed no
differences between genotypes at 0.5 year of age, but we observed a
significant decrease in 1-year-old Super-Ink4/Arf compared with WT
mice of the same age (Fig. 3B). Thus, increased Ink/Arf gene dosage
prevents the development of age-dependent deterioration of glucose
metabolism, but this is not accompanied by enhanced insulin secretion.
To investigate whether insulin sensitivity was affected in these mice, we
performed insulin tolerance tests (ITT) in 0.5- and 1-year-old mice of
both genotypes (Fig. 3C). These studies revealed faster glucose disap-
pearance in Super-Ink4/Arf mice compared with WT mice after insulin
injection, suggesting that increased Ink4/Arf gene dosage augments
insulin sensitivity.
To evaluate the effect of increased insulin sensitivity on in vivo
glucose disposal and uptake, we performed 18F-fluorodeoxyglucose
(18F-FDG) Positron Emission Tomography (PET)–Computer Tomography
(CT) imaging studies. To this end, 1-year-old mice were intraperito-
neally injected with 18F-FDG and after 60 minutes of uptake, skeletal
muscle was analyzed by PET–CT imaging (Fig. 4A). Quantification of
the standard uptake value (SUV) showed an almost significant
increase in18F-FDG uptake in soleus muscle from Super-Ink4/Arf mice
compared with WT mice (Fig. 4B, P = 0.079). Furthermore, regression
analysis demonstrated a positive correlation between 18F-FDG uptake
and baseline glucose levels in Super-Ink4/Arf mice but not in WT
mice (Fig. 4C), suggesting that WT mice are insensitive to glucose
levels.
Super-Ink4/Arf mice exhibit increased insulin sensitivity in
liver and peripheral tissues
To further characterize insulin sensitivity in age-associated glucose and
insulin derangements inWT and Super-Ink4/Arfmice, we analyzed insulin
signaling pathway activation in vivo. Insulin exerts its actions through
binding to its receptor (INS-R) and the ensuing phosphorylation of IRS at
tyrosine residues (pTyr) and activation of PI3K/AKT-dependent signaling.
As ablation or defective INS-R/IRS/AKT-mediated signaling in a variety of
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tissues causesmajor alterations in glucose homeostasis and leads to insulin
resistance and T2DM (Withers et al., 1998; Cho et al., 2001; Gonzalez-
Navarro et al., 2007, 2008) we analyzed IRS-AKT pathway activation in
liver and peripheral tissues of 1-year-old WT and Super-Ink4/Arf mice
treated with insulin. Coimmunoprecipitation experiments followed by
Western blot analysis revealed reduced levels of insulin-induced pTyr-IRS1
and pTyr-IRS2 accumulation in WT compared with Super-Ink4/Arf liver
(Figure 5A, B). IRS1 or IRS2 associated with the PI3K regulatory subunit
p85a was similar in the liver of insulin-stimulated WT and Super-Ink4/Arf
mice (Fig. 5A, B). Analysis of hepatic IRS1 and IRS2 protein and mRNA
levels showed no differences between genotypes (Fig. 5C).
We next examined in peripheral tissues of 1-year-old mice the
activation of AKT1/2 using a phospho-specific antibody to detect
phospho-AKT1/2 (pAKT1/2). Consistent with our results in liver, we
found diminished amount of insulin-stimulated pAKT1/2 in skeletal
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Fig. 1 Ink4/Arf locus expression and function in 1-year-old Super-Ink4/Arf and WT mice. (A) Structure of the transgene used for the generation of Ink4/Arf transgenic
mice. The transgene contains the complete exon structure of the three genes, Ink4b, Arf, and Ink4a. Boxes labeled SP6 and T7 represent short terminal sequences (of 20 bp)
used for the identification of the transgene by PCR. (B) p16Ink4a, p15Ink4b, and p19Arf mRNA expression in liver, skeletal muscle, heart, and isolated pancreatic islets
quantified by qPCR. mRNA levels were normalized to endogenous cyclophilin levels and relativized to WT mRNA levels (=1). N.D.: not detected. (C) Protein lysates
(liver, skeletal muscle, heart: 250 lg; isolated islets: 75 lg) were subjected to Western blot analysis using antibodies against p16Ink4a, p15Ink4b, p19Arf, and b-actin.
Representative blots are shown and quantifications in the graphs represent the average of 4-8 independent blots. Protein levels were normalized to b-actin levels.
(D) Bone-marrow-derived macrophages were untreated (basal) or irradiated with UV light (80 J/m2) to induce apoptosis. After propidium iodide staining, apoptotic cells were
identified by flow cytometry as the sub-G0 population. Statistical analysis was carried out using two-way ANOVA (B, C) and Student’s t-test (D).
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changes in total AKT1/2 (Fig. 6). As enhanced basal activation of JNK has
been associated with decreased IRS1 in insulin resistance (Hirosumi
et al., 2002), we examined the phosphorylation status of this mitogen-
activated protein kinase. However, the amount of pJNK was similar in
control and insulin-stimulated skeletal muscle (Fig. 6A) and heart
(Fig. 6B) of WT and Super-Ink4/Arf mice. Altogether, these results
indicate that improved insulin sensitivity in liver and peripheral tissues
contributes to protection against age-associated glucose and insulin
derangements in Super-Ink4/Arf mice.
Discussion
Recent human genome-wide association studies and candidate gene
strategies have linked common single nucleotide polymorphisms in a
region of chromosome 9p21 near the Ink4/Arf locus with aging-
associated diseases which have an important impact on public health,
including coronary artery disease, myocardial infarction, stroke, and
T2DM (Consortium, 2007; Melzer et al., 2007; Saxena et al., 2007;
Scott et al., 2007; Sharpless & DePinho, 2007; Zeggini et al., 2007;
Doria et al., 2008; Hamsten & Eriksson, 2008). However, additional
work is required to define the functional consequences of these genetic
variants and to ascertain whether Ink4/Arf plays a role in the develop-
ment of cardiovascular disease and T2DM associated with aging. In the
present study, we evaluated the impact of moderately increasing Ink4/
Arf expression on glucose and insulin homeostasis during normal aging.
Our results demonstrate that transgenic Super-Ink4/Arf mice carrying
one intact additional copy of the Ink4/Arf locus are protected against
the aging-associated alterations in glucose homeostasis normally seen in
WT mice, including increased glycaemia, glucose intolerance, and insulin
resistance. This protective function of Ink4/Arf gain-of-function was not
associated with changes in either islet number, pancreatic b-cell area, or
b-cell proliferation (Figure S1), but coincided with increased sensitivity to
insulin in peripheral tissues. Our results demonstrate that insulin-
stimulated activation of IRS-PI3K-AKT-dependent signaling was greater
in liver, skeletal muscle, and heart of Super-Ink4/Arf mice than in WT
controls. In agreement with enhanced insulin sensitivity and signaling
and lower glucose levels, Super-Ink4/Arf mice exhibited an almost
significant increase in glucose uptake in skeletal muscle compared with
WT mice. Furthermore, a positive correlation between glucose uptake
and baseline glucose levels was observed in Super-Ink4/Arf but not inWT
mice. Taken together, our results suggest that a moderate increase in
Ink4/Arf function prevents age-associated derangements in glucose
metabolism and insulin resistance by improving insulin-dependent
activation of IRS-PI3K-AKT signaling. In agreement with previous studies
showing that Ink4/Arf expression is low in young animals and increases
in several tissues during aging (reviewed in (Krishnamurthy et al., 2004))
and that Ink4/Arf expression is only moderately upregulated in tissues
from ~1.5-year-old Super-Ink4/Arf mice (Matheu et al., 2004), we only
observed a modest increase in Ink4/Arf mRNA and protein levels in the
liver of 1-year-old Super-Ink4/Arf mice (Fig. 1B, C). Importantly,
however, this modest upregulation has functional consequences, as
demonstrated by higher UV-induced apoptosis in Super-Ink4Arf bone-
marrow-derived macrophages (Fig. 1D).
Aging is associated with augmented susceptibility to the development
of T2DM and other metabolic diseases (Rhodes, 2005), and with
increased expression of Ink4/Arf in several human and mouse tissues
(Zindy et al., 1997; Krishnamurthy et al., 2004; Ressler et al., 2006). In
addition to promoting senescence of somatic cells, age-dependent up-
regulation of Ink4/Arf might contribute to organismal aging by limiting
the regenerative potential of stem cell pools (Krishnamurthy et al.,
2004). Importantly, Baker et al. recently reported that clearance of
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Fig. 2 Effect of increased gene dosage of Ink4/Arf on plasmatic glucose, insulin, and cholesterol. (A) Body weight of WT and Super-Ink4/Arf mice of the indicated ages.
Mice were fasted overnight to measure plasma glucose (B), insulin (C), and cholesterol (D, E). Statistical analysis was performed using one-way ANOVA.
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BubR1 progeroid mouse background (Baker et al., 2008). However,
evidence exists that Ink4/Arf can also elicit beneficial effects. Thus,
Super-Ink4/Arfmice, which carry one extra copy of Ink4/Arf and exhibit a
moderate increase in p16Ink4a, p15Ink4b, and p19Arf expression in a
number of tissues at old ages, are more resistant to cancer than controls
and have normal aging and lifespan (Matheu et al., 2004). Moreover,
introduction of two intact additional copies of the Ink4/Arf locus in
transgenic mice increases cancer resistance and extends lifespan
probably by favoring quiescence and preventing unnecessary cell
proliferation (Matheu et al., 2009). The Ink4/Arf locus also exerts
atheroprotective functions, because increased atherosclerosis was
observed in apolipoprotein-E deficient mice with global ablation of
p19Arf (Gonzalez-Navarro et al., 2010) and in LDL-receptor-deficient
mice with macrophage-specific deficiency of the CDKN2A gene, which
encodes p16Ink4a and p19Arf (Kuo et al., 2011). The results of the present
study provide additional evidence that this locus can exert beneficial
effects at the organismal level beyond cancer protection.
Aging in humans and mice is associated with loss of insulin
sensitivity and hyperinsulinemia (Rhodes, 2005). Moreover, impaired
signaling through INS-R/IRS/AKT in a variety of tissues (including b-cells,
adipocytes, leukocytes, hepatocytes) leads to insulin resistance and
T2DM (Withers et al., 1998; Cho et al., 2001; Gonzalez-Navarro et al.,
2007, 2008). Consistent with these results, we observed that glucose
tolerance declines in 1-year-old WT but not in age-matched Super-
Ink4/Arf mice. This is explained, at least in part, because insulin-
mediated activation of IRS-PI3K-AKT signaling in liver, skeletal muscle,
and heart is enhanced as compared with age-matched control mice.
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Fig. 3 Increased gene dosage of Ink4/Arf improves glucose tolerance and insulin sensitivity in mice. (A, B) Glucose tolerance test (GTT) was performed in 0.5- and
1-year-old WT and Super-Ink4/Arf mice. The graphs show the plasmatic levels of glucose (A) and insulin (B) at the different time points analyzed during the test. These
values were used to calculate the area under the curve (AUC) (shown in the graphs in the right). (C) ITTs were performed in 0.5- and 1-year-old mice 4 h after food removal.
The graphs in the left show levels of glucose at different time points analyzed during the test (relative to initial glucose level). The graph in the right depicts the AUCs.
Statistical analysis was performed using one-way ANOVA.
Role of Ink4/Arf in diabetes associated with aging, H. Gonzalez-Navarro et al.106
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
uptake in skeletal muscle and decreased glucose levels in Super-Ink4/
Arf mice. Our studies suggest that a moderate increase in Ink4/Arf
function may represent a logical target for treating or delaying age-
related development of insulin resistance and carbohydrate metabolism
derangement.
It has been shown that HOMA-IR in patients is strongly modulated
by variants in CDKN2B (Ruchat et al., 2009). However, some studies
suggest that the 9p21 SNPs are associated with reduced islet function,
such as decreased insulin secretion (Ruchat et al., 2009; Stancakova
et al., 2009 Hribal et al., 2011), and not with differences in insulin
resistance (Hribal et al., 2011) and body mass (Hotta et al., 2012). We
found that moderately increased expression of the entire Ink4/Arf
locus in Super-Ink4/Arf mice does not alter islet number, b-cell area, or
functionality during physiological aging (Figure S1), but rather appears
to protect against age-associated glucose intolerance and insulin
resistance. However, previous studies have shown that deficiency in
p16ink4a enhances islet proliferation and survival in mice with
streptozotocin-induced b-cell ablation. Moreover, p16ink4a overexpres-
sion decreases islet proliferation suggesting that increase of p16ink4a
expression might limit the regenerative capacity of b-cells (Krishna-
murthy et al., 2006). It should be noted that streptozotocin treatment,
a model of Type 1 diabetes, probably involves acute mitogenic
stimulation and high level of p16ink4a expression, which has been
shown to occur during regeneration after acute damage of a variety
of tissues such as fat, skeletal muscle, hematopoietic system, nervous
system, and endocrine pancreas (Janzen et al., 2006; Krishnamurthy
et al., 2006; Molofsky et al., 2006; Baker et al., 2008). However, this
might not be predictive of the long-term consequences of moderately
increased p16ink4a in nonacute models, such as in the studies reported
here. Our observations that Super-Ink4/Arf mice do not exhibit
alterations in islet number, b-cell area, or functionality during
physiological aging are not unprecedented, as Kir6.2, a component
of the K-ATP channels that promotes insulin secretion in b-cells, is a
direct target of E2F1 (Annicotte et al., 2009). These results suggest
that both the Ink4/Arf and CDK4–pRB–E2F1 pathways regulate
glucose homeostasis without affecting b-cell proliferation. Additional
studies using loss-of-function and tissue-specific genetic manipulation
in the mouse should address the impact of p16ink4a, p19Arf, and
p15ink4b on islet function during aging in order to dissect the precise




Care of animals was in accordance with institutional guidelines and
regulations. Transgenic Super-Ink4/Arf mice used in this study carried
one extra copy of the entire Ink4/Arf locus, which consisted of a 77 kb
sequence that contained the complete exon structure flanked with two
20 bp short nucleotide sequences used for the identification of the
transgene by PCR (Matheu et al., 2004) (Fig. 1A). Transgenic mice
were obtained after 20 backcrosses into C57BL6 background and were
heterozygous for the additional Ink4/Arf locus. Siblings obtained by
crossing C57BL6 WT and SuperInk4Arf mice were analyzed. Mice were
genotyped for the presence of the extra Ink4/Arf gene dosage using
two independent PCR reactions as previously described (Matheu et al.,
2004). Mice were kept on a low-fat standard diet (2.8% fat; Panlab,
Barcelona, Spain) and sacrificed at 0.5 (mice between 5–7 months of
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Fig. 4 Effect of the increased dosage of the locus Ink4/Arf on 18F-FDG uptake in skeletal muscle in vivo. (A) Representative scans fromWT and Super-Ink4/Arfmice showing
transaxial images of the lower section of the mouse body (Top: CT, middle: PET; bottom: fused PET/CT). The image in the right shows whole-body PET. Lines in the image
delineate the VOI in the soleus muscle used for analysis. (B) 18F- FDG uptake in soleus muscle measured by PET scan. (C) Regression analysis of 18F- FDG uptake (SUV) as a
function of blood glucose levels. Each point represents one animal. Statistical analysis was performed using t-test (B) or F-test (C).
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Metabolic measurements
Plasma cholesterol levels in mice fasted overnight were measured using
enzymatic procedures (Wako, St. Louis, USA). HDL-cholesterol (HDL-C)
was determined after precipitation of the apoB-containing lipoproteins
with Heparin Calcium (Sigma, St. Louis, MI, USA) (Gonzalez-Navarro
et al., 2007). For GTTs, mice received an intraperitoneal injection of
glucose (2 g/Kg of body weight; Sigma) and plasma glucose and insulin
levels were analyzed at different time points using a glucometer
(Ascensia Elite, Bayer, Leverkusen, Germany) and ultrasensitive anti-
mouse insulin ELISA (Mercodia, Uppsala, Sweden), respectively. For ITTs,
mice fasted for 4 h received an intraperitoneal injection of insulin
(Actrapid, Novo Nordisk, Madrid, Spain, 0.25 U/Kg of body weight), and
plasma glucose levels were measured from tail blood at different time
points using a glucometer.
In vivo insulin signaling studies
Anesthetized fasted mice (15 h) were injected with Humulina Regular
(Lilly, Indianapolis, IN, USA, 0.25 U of insulin/g of BW) in the hepatic
vein and killed 5 min later. Liver, skeletal muscle, and heart were
removed and rapidly frozen in liquid N2 for protein extraction. Two mice
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Fig. 5 Augmented gene dosage of Ink4/Arf increases insulin-induced signaling in the liver of 1-year-old mice. (A, B) Fasted mice were treated with insulin and sacrificed
after 5 min to prepare liver protein lysates, which were subjected to immunoprecipitation with anti-IRS1 (A) or anti-IRS2 (B) antibodies and analyzed by western blot using
anti-phospho-tyrosine (anti-pTyr) or anti-p85a antibodies. Representative blots are shown on the left. The graphs show relative levels of expression (average of 4
independent blots) (protein levels were relativized to unstimulated mice of the same genotype). (C) IRS1 and IRS2 protein (left) and mRNA (right) expression in liver. Liver
protein lysates were subjected to immunoprecipitation with anti-IRS1 or anti-IRS2 antibodies and analyzed by western blot (WB). Representative blots are shown. The
numbers below each blot show band intensity determined by densitometry after averaging 4 independent experiments (relative to WT mice). mRNA levels were normalized
to cyclophilin mRNA levels and relativized to WT mouse expression.
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In vivo PET–CT imaging to study 18F-FDG skeletal muscle
uptake
Nonfasted mice were injected intraperitoneally with 11.1 MBq (300 of
lCi in 0.2 mL of 0.9% NaCl) of the radiotracer 18F-FDG. After an uptake
period of 60 min, mice were anesthetized (2% isofluorane) to assure
immobilization during the scanning process and placed on the bed of the
tomography. PET acquisition was performed during 20 min, followed by
a CT scanning using a specific small animal PET–CT hybrid tomograph
(Albira ARS, Oncovision, Valencia, Spain) with an image resolution of
<1.5 mm and a 8-cm transaxial, and a 4-cm axial field of view. The
tomographic images were reconstructed by applying an ordered subset
expectation maximization algorithm for the PET and a filtered back
projection for the CT images. To evaluate 18F-FDG uptake in the skeletal
muscle, the volume of interest (VOI) was delineated around the soleus
muscle, which consisted of 8 consecutive piled ellipse of 0.0125 mm
thickness. The VOIs were then transferred to PET–CT coregistered
images to obtain the average activity of the soleus FDG uptake (kBq/cc).
For quantification purposes, the SUV was calculated as a ratio of tissue
radioactivity concentration (kBq/cc) at the time of PET acquisition and
injected dose (KBq) divided by body weight (g). All these processes of
visualization, coregistration and quantification were performed using the
PMOD 3.0 suite (Pmod Technologies, Zurich, Switzerland).
Isolation of pancreatic islets
For islet isolation, mice were infused with Krebs buffer (127mM NaCl,
5 mM KCl, 3 mM CaCl2, 1.5 mM MgCl2, 24 mM NaHCO3, 6 mM Hepes,
2 mg/mL glucose, 0.1% albumin, equilibrated with 5% CO2 in O2).
Pancreas were dissected from mice and digested with collagenase-NB8
(1 mg/mL, 17456, Serva, Heidelberg, Germany) in Krebs solution at 37 °
C in a shaking water bath during 20 min. After washing with Krebs
(800 g, 1 min), islets were handpicked under stereoscope, collected
(500 g, 1 min) and frozen with liquid N2 for RNA and protein analysis.
Coimmunoprecipitation and western blot analysis
Protein extracts were obtained from different tissues using a homoge-
nizer in the presence of the ice-cold lysis TNG buffer (50 mM Tris-HCI,
pH7.5, 200 mM NaCl, 1% Tween-20, 0.2% NP-40) supplemented with
Complete Mini cocktail (Roche, Mannheim, Germany), 50 mM ß-
glycerolphosphate (Sigma), 2 mM PhenylMethylSulfonyl Fluorid (PMSF;
Roche), and 200 lM Na3VO (Sigma).
For coimmunoprecipitation analysis, protein extracts (500 lg) were
incubated 1 h 4 °C with 2 lg of rabbit polyclonal anti-IRS1 (sc-559
SANTACRUZ, Santa Cruz, CA, USA) or rabbit polyclonal anti-IRS2 (sc-
8299, SANTACRUZ), followed by an incubation (1 h, 4 °C) with 30 lL of
50% Protein A/G PLUS-Agarose (sc-2003, SANTACRUZ). Beads were
washed twice (16 000 g, 5 s) with TNG buffer for IRS1 immunoprecip-
itation or with CLB buffer (2.5 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA and 1% Triton X100) for IRS2 immunoprecipitation.
Immunoglobulin–protein complexes were eluted from beads by boiling
in Laemmli’s buffer (30 lL) and were subjected to 8% polyacrilamide gel
electrophoresis and western blot analysis.
For whole protein analysis, protein extracts (50–250 lg) were
analyzed by 12% polyacrilamide gel electrophoresis (for analysis of the
insulin-signaling proteins) or 15% polyacrilamide gel electrophoresis (for
Ink4/Arf proteins analysis) followed by western blot (Gonzalez-Navarro
et al., 2008).
The following primary antibodies were used for the western blot
analysis: rabbit anti-SAPK/JNK (56G8) (1/500, 9258, Cell Signaling,
Danvers, MA, USA), rabbit anti-phospho-SAPK/JNK (Thr183/Tyr185) (1/
500 2994, Cell Signaling), rabbit polyclonal IgG anti-phospho-Akt
(Ser473) (1/250, 9271 Cell Signaling), goat polyclonal IgG anti-Akt1/2
(1/1000, sc-1619), mouse anti-phospho-Tyr (1/500, clon 4G10, 05-321,
UPSTATE, Millipore, Madrid, Spain), rabbit anti-p85a (1/500, 06-195,
UPSTATE), rabbit anti-IRS2 (1/200, 06-506, UPSTATE), rabbit anti-IRS1
(1/1000, 2382 Cell Signaling), rabbit anti-p16ink4a and anti-p19Arf (1/
200, sc-1207 and sc-32748, respectively, SANTACRUZ), rabbit anti-
p15ink4b (1/500, 4822 Cell Signaling), and mouse anti-b-actin (1/500,
A5441, Sigma). HRP conjugated secondary antibodies (1/300) from
SANTACRUZ were as follows: anti-mouse IgG-HRP (sc-2031), goat anti-
rabbit IgG-HRP (sc-2004), and donkey anti-goat IgG-HRP (sc-2056).
Immunocomplexes were detected with ECL Plus detection kit (GE
Healthcare, ThermoFisher, Barcelona, Spain). For quantification of
protein levels, we performed densitometry scanning of protein bands.


































































Fig. 6 Increased gene dosage of Ink4/Arf improves peripheral insulin signaling
in 1-year-old mice. Fasted mice were treated with insulin and sacrificed after 5 min
to prepare skeletal muscle (A) and heart (B) protein lysates, which were subjected
to Western blot analysis using antibodies against phospho-AKT1/2 (pAKT1/2),
AKT1/2, phospho-JNK (pJNK), JNK, and b-actin. Representative blots are shown on
the left. The graphs show relative levels of expression (average of 4 independent
blots). Phosphorylated (active) forms of each protein were normalized to total
protein levels and are shown relative to unstimulated mice of the same genotype.
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forms of the protein or to b-actin for total protein extracts in Western
blots, and to unstimulated protein levels in coimmunoprecipitations
assays.
Gene expression analysis by quantitative real-time PCR
(qPCR)
RNA from liver, skeletal muscle, heart, and isolated pancreatic islets (50–
80 islets per sample) of 1-year-old mice was obtained using TRIzol
Reagent (Invitrogen, Life Technologies, Madrid, Spain) and a homog-
enizer. RNA purity and concentration were determined by the A260/280
ratio, and RNA (0.5–1 lg) was retrotranscribed and amplified with
SuperScript III First Strand Synthesis Supermix and Platinum SYBR Green
qPCR Supermix-UDG with Rox dye (Invitrogen). Reactions were run on a
thermal Cycler 7900 Fast System (liver and heart: 1 cycle of 95 °C
10 min, 40 cycles 95 °C 15 s, 60 °C 1 min; isolated islets and skeletal
muscle: 1 cycle of 95 °C 10 min, 50 cycles 95 °C 15 s, 60 °C 1 min),
and results were analyzed with the software provided by the manufac-
turer (Applied Biosystems, Life Technologies). The following primers
(Forward: Fw; Reverse: Rv) were used: cyclophilin (Fw: 5′ TGGAGAGC
ACCAAGACAGACA-3′ and Rv 5′-TGCCGGAGTCGACAATGAT-3′); irs1
(Fw: 5′-CGGAGAGCGATGGCTTCTC-3′ and Rv: 5′-GTTTGTGCATGCTCT
TGGGTTT-3′); irs2 (Fw: 5′-CGGTCGACTGCTGTCT GAAC-3′ and Rv:
5′-GAGGGCGATCAGGTACTTGTG-3′). p15Ink4b (Fw 5 ′-AGATCCCAAC-
GCCCTGAAC-3′ and Rv 5′-CCCATCATCATGACCTGG ATT-3′); p16Inka
(Fw:5′-CGTACCCCGATTCAGGTGAT-3′; Rv: 5′-TTGAG CAGAAGAGCT
GCTACGT-3′); and p19Arf (Fw:5′-TCTTGAGAAGAGGGCCGCACC-3′
and Rv:5′-GAATCTGCACCGTAGTTGAGC-3′).
Apoptosis analysis in bone-marrow-derived macrophages
Bone-marrow-derived macrophages were obtained from femoral bone
marrow and differentiated (1 9 106 cells/mL) 7 days in DMEM P/S, 10%
fetal bovine serum and 10% L929-cell conditioned medium (as a source
of macrophage colony-stimulating factor). To induce apoptosis, macro-
phages were exposed to ultraviolet light (80 J/m2). After 24 h, cells were
trypsinized, collected by centrifugation (5 min, 400 g), fixed with 80%
ethanol (30 min, 20 °C), and labeled 30 min at room temperature
with propidium iodide solution (50 lg/mL, RNase A, 0.025 mg/mL).
Apoptotic hypodiploid cells were detected by flow cytometry (FACSC-
anto, BD Biosciences, Madrid, Spain) .
Statistical analysis
Data are presented as mean  SEM. Differences among groups were
evaluated by Student’s t-test (GraphPad Prism Software, Inc, La Jolla,
CA, USA) or one-way ANOVA with Fisher’s post hoc test (Statview, SAS
institute, Cary, USA). F-test was used for regression analysis. Outliers
identified by Grubb′s test were not considered for quantification.
Statistical significance was taken at P < 0.05.
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Figure S1. Increased gene dosage of Ink4/Arf does not affect pancreatic islet
number and area or b-cell proliferation in 1-year-old mice.
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